1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Monotherapy 1.2.3 Combination Therapy 1.3 Market by Application 1.3.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Breast Cancer 1.3.3 Gastric Cancer 1.3.4 Ovarian Cancer 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Perspective (2016-2027) 2.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Growth Trends by Regions 2.2.1 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Share by Regions (2016-2021) 2.2.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Regions (2022-2027) 2.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Industry Dynamic 2.3.1 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Trends 2.3.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Drivers 2.3.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Challenges 2.3.4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Revenue 3.1.1 Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Revenue (2016-2021) 3.1.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Players (2016-2021) 3.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue 3.4 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Concentration Ratio 3.4.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue in 2020 3.5 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Key Players Head office and Area Served 3.6 Key Players HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Solution and Service 3.7 Date of Enter into HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market 3.8 Mergers & Acquisitions, Expansion Plans 4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Breakdown Data by Type 4.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Type (2016-2021) 4.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Type (2022-2027) 5 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Breakdown Data by Application 5.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Application (2016-2021) 5.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2016-2027) 6.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type 6.2.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) 6.2.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) 6.2.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2027) 6.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application 6.3.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) 6.3.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) 6.3.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2027) 6.4 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country 6.4.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021) 6.4.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2016-2027) 7.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type 7.2.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) 7.2.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) 7.2.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2027) 7.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application 7.3.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) 7.3.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) 7.3.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2027) 7.4 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country 7.4.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021) 7.4.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2016-2027) 8.2 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type 8.2.1 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) 8.2.2 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) 8.2.3 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2027) 8.3 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application 8.3.1 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) 8.3.2 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) 8.3.3 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2027) 8.4 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region 8.4.1 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2016-2021) 8.4.2 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2016-2027) 9.2 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type 9.2.1 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) 9.2.2 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) 9.2.3 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2027) 9.3 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application 9.3.1 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) 9.3.2 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) 9.3.3 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2027) 9.4 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country 9.4.1 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021) 9.4.2 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2016-2027) 10.2 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type 10.2.1 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) 10.2.2 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) 10.2.3 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2027) 10.3 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application 10.3.1 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) 10.3.2 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) 10.3.3 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2027) 10.4 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country 10.4.1 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021) 10.4.2 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 F. Hoffmann-La Roche Ltd 11.1.1 F. Hoffmann-La Roche Ltd Company Details 11.1.2 F. Hoffmann-La Roche Ltd Business Overview 11.1.3 F. Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction 11.1.4 F. Hoffmann-La Roche Ltd Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) 11.1.5 F. Hoffmann-La Roche Ltd Recent Development 11.2 Merck & Co., Inc 11.2.1 Merck & Co., Inc Company Details 11.2.2 Merck & Co., Inc Business Overview 11.2.3 Merck & Co., Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction 11.2.4 Merck & Co., Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) 11.2.5 Merck & Co., Inc Recent Development 11.3 Novartis AG 11.3.1 Novartis AG Company Details 11.3.2 Novartis AG Business Overview 11.3.3 Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction 11.3.4 Novartis AG Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) 11.3.5 Novartis AG Recent Development 11.4 Pfizer Inc 11.4.1 Pfizer Inc Company Details 11.4.2 Pfizer Inc Business Overview 11.4.3 Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction 11.4.4 Pfizer Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) 11.4.5 Pfizer Inc Recent Development 11.5 Puma Biotechnology, Inc 11.5.1 Puma Biotechnology, Inc Company Details 11.5.2 Puma Biotechnology, Inc Business Overview 11.5.3 Puma Biotechnology, Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction 11.5.4 Puma Biotechnology, Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) 11.5.5 Puma Biotechnology, Inc Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Monotherapy Table 3. Key Players of Combination Therapy Table 4. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Regions (2016-2021) Table 8. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Regions (2022-2027) Table 10. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Trends Table 11. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Drivers Table 12. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Challenges Table 13. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Restraints Table 14. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue by Players (2016-2021) & (US$ Million) Table 15. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Players (2016-2021) Table 16. Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors as of 2020) Table 17. Ranking of Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Solution and Service Table 21. Date of Enter into HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) (US$ Million) Table 24. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2016-2021) Table 25. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Application (2016-2021) Table 29. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) (US$ Million) Table 32. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million) Table 33. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) (US$ Million) Table 34. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million) Table 35. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021) & (US$ Million) Table 36. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) (US$ Million) Table 38. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) (US$ Million) Table 40. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027) & (US$ Million) Table 61. F. Hoffmann-La Roche Ltd Company Details Table 62. F. Hoffmann-La Roche Ltd Business Overview Table 63. F. Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Table 64. F. Hoffmann-La Roche Ltd Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) & (US$ Million) Table 65. F. Hoffmann-La Roche Ltd Recent Development Table 66. Merck & Co., Inc Company Details Table 67. Merck & Co., Inc Business Overview Table 68. Merck & Co., Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Table 69. Merck & Co., Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) & (US$ Million) Table 70. Merck & Co., Inc Recent Development Table 71. Novartis AG Company Details Table 72. Novartis AG Business Overview Table 73. Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Table 74. Novartis AG Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) & (US$ Million) Table 75. Novartis AG Recent Development Table 76. Pfizer Inc Company Details Table 77. Pfizer Inc Business Overview Table 78. Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Table 79. Pfizer Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) & (US$ Million) Table 80. Pfizer Inc Recent Development Table 81. Puma Biotechnology, Inc Company Details Table 82. Puma Biotechnology, Inc Business Overview Table 83. Puma Biotechnology, Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Table 84. Puma Biotechnology, Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) & (US$ Million) Table 85. Puma Biotechnology, Inc Recent Development Table 86. Research Programs/Design for This Report Table 87. Key Data Information from Secondary Sources Table 88. Key Data Information from Primary Sources List of Figures Figure 1. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type: 2020 VS 2027 Figure 2. Monotherapy Features Figure 3. Combination Therapy Features Figure 4. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application: 2020 VS 2027 Figure 5. Breast Cancer Case Studies Figure 6. Gastric Cancer Case Studies Figure 7. Ovarian Cancer Case Studies Figure 8. Others Case Studies Figure 9. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Report Years Considered Figure 10. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Regions: 2020 VS 2027 Figure 13. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Regions (2022-2027) Figure 14. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Players in 2020 Figure 15. Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors as of 2020 Figure 16. The Top 10 and 5 Players Market Share by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue in 2020 Figure 17. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2016-2021) Figure 18. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2022-2027) Figure 19. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2016-2027) Figure 21. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2016-2027) Figure 22. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2016-2027) Figure 23. United States HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2016-2027) Figure 27. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2016-2027) Figure 28. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2016-2027) Figure 29. Germany HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2016-2027) Figure 37. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2016-2027) Figure 38. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2016-2027) Figure 39. China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2016-2027) Figure 47. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2016-2027) Figure 48. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2016-2027) Figure 49. Mexico HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2016-2027) Figure 53. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2016-2027) Figure 54. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2016-2027) Figure 55. Turkey HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. F. Hoffmann-La Roche Ltd Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) Figure 59. Merck & Co., Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) Figure 60. Novartis AG Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) Figure 61. Pfizer Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) Figure 62. Puma Biotechnology, Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

F. Hoffmann-La Roche Ltd Merck & Co., Inc Novartis AG Pfizer Inc Puma Biotechnology, Inc